Can tolerogenic dendritic cells help to modulate allo-immune responses in the setting of hematopoietic cell transplantation?
- 30 September 2003
- journal article
- review article
- Published by Elsevier BV in Transplant Immunology
- Vol. 11 (3-4), 259-266
- https://doi.org/10.1016/s0966-3274(03)00053-4
Abstract
No abstract availableThis publication has 73 references indexed in Scilit:
- Mouse CD11c+ B220+ Gr1+plasmacytoid dendritic cells develop independently of the T-cell lineageBlood, 2002
- Novel therapeutics for the treatment of graft-versus-host diseaseExpert Opinion on Investigational Drugs, 2002
- Characterization of a new subpopulation of mouse CD8α+ B220+ dendritic cells endowed with type 1 interferon production capacity and tolerogenic potentialBlood, 2002
- Mouse and human dendritic cell subtypesNature Reviews Immunology, 2002
- DENDRITIC CELLS: TO WHERE DO THEY LEAD?Transplantation, 2002
- The Immunopathophysiology of Acute Graft‐Versus‐Host‐DiseaseThe International Journal of Cell Cloning, 1996
- T-cell depletion of HLA-identical transplants in leukemiaBlood, 1991
- Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemiaBlood, 1991
- Graft-versus-Host DiseaseNew England Journal of Medicine, 1991
- IMPACT OF T-CELL DEPLETION ON OUTCOME OF ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR STANDARD-RISK LEUKAEMIASThe Lancet, 1987